Pr. Galle et al., INVOLVEMENT OF THE CD95 (APO-1 FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE/, The Journal of experimental medicine, 182(5), 1995, pp. 1223-1230
Apoptosis occurs in the normal liver and in various forms of liver dis
ease. The CD95 (APO-1/Fas) (CD95) receptor mediates apoptosis, and liv
er cells in animal models are acutely sensitive to apoptosis initiated
by this receptor. We have used primary human hepatocytes as a model s
ystem to investigate CD95-mediated apoptotic liver damage. Treatment o
f fresh human hepatocytes with low concentrations of agonistic antibod
ies against CD95 resulted in apoptosis of >95% of the cultured liver c
ells within 4 and 7.5 h. Immunohistology of a panel of explanted liver
tissues revealed that hepatocytes in normal livers (n = 5) and in alc
oholic cirrhosis (n = 13) expressed low constitutive levels of CD95. C
D95 receptor expression was highly elevated in hepatocytes in hepatiti
s B virus-related cirrhosis (n = 9) and in acute liver failure (n = 8)
. By in situ hybridization CD95 ligand messenger RNA expression was ab
sent in normal liver but detected at high levels in livers with ongoin
g Liver damage. In cases of hepatitis B virus-related cirrhosis and ac
ute hepatic failure, ligand expression was found primarily in areas wi
th lymphocytic infiltration. In contrast, in patients with alcoholic l
iver damage, high CD95 Ligand messenger RNA expression was found in he
patocytes. These findings suggest that liver destruction in hepatitis
B may primarily involve killing of hepatocytes by T lymphocytes using
the CD95 receptor-ligand system. In alcoholic liver damage, death of h
epatocytes might occur by fratricide and paracrine or autocrine mechan
isms mediated by the hepatocytes themselves.